title: The top ten fallacies of nonsustained ventricular tachycardia.
abstract: Nonsustained ventricular tachycardia (NSVT) continues to remain a subject of controversy. This is true despite a wealth of epidemiologic and basic/clinical laboratory findings that have accumulated during the past 2 decades. However, these data not only generate the impetus to conduct further research, but also provide compelling arguments against continued adherence to time honored precepts about NSVT that evolved since the inception of the "PVC Hypothesis," although never substantiated by rigorous scientific inquiry. This paper discusses the "top ten" fallacies of NSVT and details the data that support abandonment of them.
authors.affiliation: Division of Cardiovascular Diseases, Lankenau Hospital and Medical Research Center, Wynnewood, Pennsylvania, USA.
authors.forename: R A
authors.initials: RA
authors.lastname: Marinchak
authors.forename: S J
authors.initials: SJ
authors.lastname: Rials
authors.forename: R A
authors.initials: RA
authors.lastname: Filart
authors.forename: P R
authors.initials: PR
authors.lastname: Kowey
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002304:Cardiac Pacing, Artificial / Q000379:methods; D002311:Cardiomyopathy, Dilated / Q000150:complications; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications; D003327:Coronary Disease / Q000150:complications; D003937:Diagnosis, Differential; D004562:Electrocardiography / Q000379:methods*; D006801:Humans; D011379:Prognosis; D012307:Risk Factors; D012449:Safety; D015996:Survival Rate; D017180:Tachycardia, Ventricular / Q000175:diagnosis / Q000209:etiology / Q000628:therapy
chemical_list: D000889:Anti-Arrhythmia Agents